Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 22, 2023

Zydus Pharms Usa Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for ZYDUS PHARMS USA INC, and what generic and branded alternatives to ZYDUS PHARMS USA INC drugs are available?

ZYDUS PHARMS USA INC has thirty-seven approved drugs.

There are seventeen tentative approvals on ZYDUS PHARMS USA INC drugs.

Summary for Zydus Pharms Usa Inc

US Patents:	0
Tradenames:	33
Ingredients:	33
NDAs:	37

Drugs and US Patents for Zydus Pharms Usa Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms Usa Inc	PIOGLITAZONE HYDROCHLORIDE	pioglitazone hydrochloride	TABLET;ORAL	202456-003	Feb 13, 2013	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa Inc	LAMOTRIGINE	lamotrigine	TABLET, FOR SUSPENSION;ORAL	078009-003	Jan 22, 2009	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa Inc	AMIODARONE HYDROCHLORIDE	amiodarone hydrochloride	TABLET;ORAL	079029-003	Jan 6, 2023	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa Inc	TAMSULOSIN HYDROCHLORIDE	tamsulosin hydrochloride	CAPSULE;ORAL	078225-001	Apr 27, 2010	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa Inc	ATOMOXETINE HYDROCHLORIDE	atomoxetine hydrochloride	CAPSULE;ORAL	079017-004	Sep 17, 2010	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa Inc	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET;ORAL	078920-001	Jul 6, 2010	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa Inc	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	078243-002	Oct 6, 2010	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA INC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Harvard Business School

Colorcon

McKesson

Moodys

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.